Time-dependent Nephrotoxicity Associated with Daily Administration of Cisplatin in Mice

The chronopharmacokinetics and chronopharmacodynamics of cisplatin were studied in a mouse model to reveal the mechanisms of dosing time‐dependent nephrotoxicity induced by daily administration. Chronotoxicity was tested by daily intraperitoneal injections of cisplatin (6 mg kg−1) for 5 days at four...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy and pharmacology 2000-12, Vol.52 (12), p.1499-1504
Main Authors: TO, HIDETO, KIKUCHI, ATSUMI, TSURUOKA, SHUICHI, SUGIMOTO, KOICHI, FUJIMURA, AKIO, HIGUCHI, SHUN, KAYAMA, FUJIO, HARA, KYOKO, MATSUNO, KOJI, KOBAYASHI, EIJI
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - adverse effects
Antineoplastic Agents - pharmacokinetics
Biological and medical sciences
Blood Urea Nitrogen
Body Weight - drug effects
Circadian Rhythm
Cisplatin - administration & dosage
Cisplatin - adverse effects
Cisplatin - blood
Creatinine - blood
Drug Administration Schedule
Drug toxicity and drugs side effects treatment
Injections, Intraperitoneal
Interleukin-6 - metabolism
Kidney - drug effects
Kidney - metabolism
Kidney - pathology
Kidney Diseases - chemically induced
Lipopolysaccharides - pharmacology
Liver - drug effects
Liver - metabolism
Male
Medical sciences
Mice
Mice, Inbred BALB C
Pharmacology. Drug treatments
Time Factors
Tissue Distribution
Toxicity: urogenital system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The chronopharmacokinetics and chronopharmacodynamics of cisplatin were studied in a mouse model to reveal the mechanisms of dosing time‐dependent nephrotoxicity induced by daily administration. Chronotoxicity was tested by daily intraperitoneal injections of cisplatin (6 mg kg−1) for 5 days at four time points (0400, 1000, 1600 and 2200h) in BALB/c mice (n = 6 in each group). After following the changes in body weight, serum concentrations of blood urea nitrogen (BUN) and creatinine obtained on day 6 were compared. In conclusion, chrononephrotoxicity induced by daily cisplatin administration does not only depend on cisplatin accumulation, but might also depend on kidney sensitivity to diurnal variations in inflammatory reaction without direct cisplatin toxicity. The results showed diurnal variations in cisplatin toxicity, with the 0400 and 1600h time points the best and the worst, respectively. We then measured platinum concentrations in blood, liver and kidney and compared the results of the 0400 and 1600 h groups (n = 4 in each group). Kidney sensitivity to cisplatin alone, lipopolysaccharide (LPS) alone, cisplatin with LPS and saline (control) were also measured using a tissue culture system (a measurement system of interleukin‐6 (IL‐6) production) between the 0400 and the 1600h groups (n = 4 in each group). These results showed no significant difference in platinum accumulation between the two groups. IL‐6 production was higher in the 1600h group than in the 0400h group after saline injection alone (P < 0.05). Cisplatin treatment alone did not increase IL‐6 production. However, IL‐6 levels were markedly augmented by cisplatin with LPS.
ISSN:0022-3573
2042-7158
DOI:10.1211/0022357001777711